Founded In
The founder team includes top scientists in the field of gene therapy, industrial experts with a background in international pharmaceutical companies, and Anping toxicology experts with preclinical drug evaluation experience.
The advisory team includes authoritative experts in gene therapy, clinicians from top-tier tertiary hospitals, and executives of listed pharmaceutical companies.
Gene Editing Transient Delivery Technology---BDgene realizes the safe and efficient delivery of CRISPR and other gene editing tools through the leading viroid BDmRNA delivery technology.
Leading lentiviral design and process platform---BDgene's advanced lentiviral vector delivery technology effectively improves the virus production and the infection efficiency of hematopoietic stem cells.